Index of /content/mda/en/publications/cancer-frontline/2019/08/triple-combination-therapy-with-nivolumab-is-feasible-for-aml-mds-patients/

NameLast ModifiedSize
UpParent Directory
Directoryjcr_content2025-05-28 20:45-
Proudly Served by LiteSpeed Web Server at mdandersoncellresearch.org Port 443